Leading the way to safer medication
 Crosscheck  Recommender

Bisoprolol

Also known as: Bisoprolol fumarate

Brand names: AMODUO (in combination) BISOCCORD BISOCOR BISOHEXAL BISOPRO BISOSTAD BISOSTAD PLUS (in combination) BLOKBIS CONCOR COSYREL (in combination) CURILEN (in combination) EMCONCOR RIVACOR RIVACOR PLUS (in combination) ZIAC (in combination)

Therapeutic Indications

Bisoprolol is indicated for:

Hypertension

Irrespective of gender only Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 5-20 mg once daily

Stable chronic angina

Irrespective of gender only Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 5-20 mg once daily

Stable chronic heart failure

Irrespective of gender only Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 1.25-10 mg once daily

Contraindications

Active ingredient Bisoprolol is contraindicated in the following cases:

Second or third degree AV block

No gender/age discrimination

Phaeochromocytoma

No gender/age discrimination

In patients with phaeochromocytoma bisoprolol must not be administered until after alpha-receptor blockade.

Severe chronic obstructive pulmonary disease

No gender/age discrimination

Sick sinus syndrome

No gender/age discrimination

Severe bronchial asthma

No gender/age discrimination

Late stages of peripheral arterial occlusive disease

No gender/age discrimination

Symptomatic hypotension

No gender/age discrimination

Symptomatic bradycardia

No gender/age discrimination

Acute heart failure

No gender/age discrimination

Metabolic acidosis

No gender/age discrimination

Sinoatrial block

No gender/age discrimination

Cardiogenic shock

No gender/age discrimination